North America Pharmacy Automation Market Research Report-Forecast till 2032

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 14 2 MARKET INTRODUCTION 16 2.1 DEFINITION 16 2.2 SCOPE OF THE STUDY 16 2.3 RESEARCH OBJECTIVE 16 2.4 MARKET STRUCTURE 17 3 RESEARCH METHODOLOGY 18 3.1 OVERVIEW 18 3.2 DATA FLOW 20 3.2.1 Data Mining Process 20 3.3 PURCHASED DATABASE: 21 3.4 SECONDARY SOURCES: 22 3.4.1 Secondary Research data flow: 23 3.5 PRIMARY RESEARCH: 24 3.5.1 Primary Research DATA FLOW: 25 3.5.2 Primary Research: Number of Interviews conducted 26 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 26 3.6.1 Revenue Analysis Approach 26 3.7 DATA FORECASTING 27 3.7.1 Data forecasting Technique 28 3.8 DATA MODELLING 29 3.8.1 microeconomic factor analysis: 29 3.8.2 Data moldelling: 30 3.9 TEAMS AND ANALYST CONTRIBUTION 32 4 MARKET DYNAMICS 34 4.1 INTRODUCTION 34 4.2 DRIVERS 35 4.2.1 Increasing incidences of chronic diseases across the north america 35 4.2.2 Increasing investment to bring technologically based solution in the North America 35 4.3 RESTRAINTS 36 4.3.1 High initial investment to set-up pharmacy automation 36   4.4 OPPORTUNITY 37 4.4.1 Growing geriatric population 37 5 MARKET FACTOR ANALYSIS 38 5.1 PORTER'S FIVE FORCES MODEL 38 5.1.1 Threat of New Entrants 38 5.1.2 BARGAINING POWER OF SUPPLIERS 39 5.1.3 Threat of Substitutes 39 5.1.4 Bargaining Power of Buyers 39 5.1.5 Intensity of Rivalry 39 5.2 IMPACT OF COVID-19 ON THE NORTH AMERICA PHARMACY AUTOMATION MARKET 40 6 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY PRODUCT 42 6.1 OVERVIEW 42 6.2 MEDICATION DISPENSING SYSTEMS 44 6.2.1 Robots/robotic automated dispensing systems 45 6.2.2 Carousels 45 6.2.3 Automated dispensing cabinets 46 6.3 PACKAGING AND LABELLING SYSTEMS 46 6.4 RX UNDERCOUNTER UNITS 46 6.5 AUTOMATED MEDICATION COMPOUNDING SYSTEMS 47 6.6 OTHERS 47 7 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY END USE 48 7.1 OVERVIEW 48 7.2 RETAIL PHARMACY 50 7.3 INPATIENT PHARMACIES 51 7.4 OUTPATIENT PHARMACIES 51 7.5 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES 52 8 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY COUNTRY 53 8.1 NORTH AMERICA 53 8.1.1 US 55 8.1.2 CANADA 57 8.1.3 Mexico 58   9 COMPETITIVE LANDSCAPE 61 9.1 INTRODUCTION 61 9.2 MARKET SHARE ANALYSIS, 2022 61 9.3 COMPETITOR DASHBOARD 62 9.4 PUBLIC PLAYERS STOCK SUMMARY 63 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 63 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 64 9.6.1 Product Launch 64 9.6.2 Collaboration 64 9.6.3 Agreement 64 9.6.4 Acquisition 65 9.6.5 Expansion 65 10 COMPANY PROFILES 66 10.1 BECTON, DICKINSON, AND COMPANY 66 10.1.1 COMPANY OVERVIEW 66 10.1.2 FINANCIAL OVERVIEW 67 10.1.3 PRODUCTS OFFERED 68 10.1.4 KEY DEVELOPMENTS 68 10.1.5 SWOT ANALYSIS 69 10.1.6 KEY STRATEGIES 69 10.2 ACCU-CHART 70 10.2.1 COMPANY OVERVIEW 70 10.2.2 FINANCIAL OVERVIEW 70 10.2.3 PRODUCTS OFFERED 71 10.2.4 KEY DEVELOPMENTS 71 10.2.5 KEY STRATEGIES 71 10.3 CAPSA HEALTHCARE 72 10.3.1 COMPANY OVERVIEW 72 10.3.2 FINANCIAL OVERVIEW 72 10.3.3 Products OFFERed 73 10.3.4 KEY DEVELOPMENTS 73 10.3.5 KEY STRATEGIES 73   10.4 ARXIUM 74 10.4.1 COMPANY OVERVIEW 74 10.4.2 FINANCIAL OVERVIEW 74 10.4.3 PRODUCTS OFFERED 75 10.4.4 KEY DEVELOPMENTS 75 10.4.5 KEY STRATEGIES 75 10.5 BAXTER 76 10.5.1 COMPANY OVERVIEW 76 10.5.2 FINANCIAL OVERVIEW 77 10.5.3 productS OFFERED 77 10.5.4 KEY DEVELOPMENTS 77 10.5.5 SWOT ANALYSIS 78 10.5.6 KEY STRATEGIES 78 10.6 SCRIPTPRO LLC 79 10.6.1 COMPANY OVERVIEW 79 10.6.2 FINANCIAL OVERVIEW 80 10.6.3 products OFFERED 80 10.6.4 KEY DEVELOPMENTS 80 10.6.5 SWOT ANALYSIS 81 10.6.6 KEY STRATEGIES 81 10.7 SWISSLOG HEALTHCARE 82 10.7.1 COMPANY OVERVIEW 82 10.7.2 FINANCIAL OVERVIEW 83 10.7.3 productS OFFERED 83 10.7.4 KEY DEVELOPMENTS 83 10.7.5 KEY STRATEGIES 83 10.8 OMNICELL, INC. 84 10.8.1 COMPANY OVERVIEW 84 10.8.2 FINANCIAL OVERVIEW 85 10.8.3 PRODUCTS OFFERED 86 10.8.4 KEY DEVELOPMENTS 86 10.8.5 SWOT ANALYSIS 87 10.8.6 KEY STRATEGIES 87   10.9 MCKESSON CORPORATION 88 10.9.1 COMPANY OVERVIEW 88 10.9.2 FINANCIAL OVERVIEW 89 10.9.3 PRODUCTS OFFERED 90 10.9.4 KEY DEVELOPMENTS 90 10.9.5 SWOT ANALYSIS 91 10.9.6 KEY STRATEGIES 91 10.10 PEARSON MEDICAL TECHNOLOGIES 92 10.10.1 COMPANY OVERVIEW 92 10.10.2 FINANCIAL OVERVIEW 93 10.10.3 PRODUCTS OFFERED 93 10.10.4 KEY DEVELOPMENTS 93 10.10.5 KEY STRATEGIES 93 11 DATA CITATIONS 94

LIST OF TABLES TABLE 1 QFD MOLDELLING FOR MARKET SHARE ASSESSMENT 30 TABLE 2 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 43 TABLE 3 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR MEDICATION DISPENSING SYSTEMS, BY COUNTRY, 2019–2032 (USD MILLION) 44 TABLE 4 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR MEDICATION DISPENSING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 45 TABLE 5 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS, BY COUNTRY, 2019–2032 (USD MILLION) 45 TABLE 6 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR CAROUSELS, BY COUNTRY, 2019–2032 (USD MILLION) 45 TABLE 7 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR AUTOMATED DISPENSING CABINETS, BY COUNTRY, 2019–2032 (USD MILLION) 46 TABLE 8 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR PACKAGING AND LABELLING SYSTEMS, BY COUNTRY, 2019–2032 (USD MILLION) 46 TABLE 9 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR RX UNDERCOUNTER UNITS, BY COUNTRY, 2019–2032 (USD MILLION) 46 TABLE 10 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR MEDICATION COMPOUNDING SYSTEMS, BY COUNTRY, 2019–2032 (USD MILLION) 47 TABLE 11 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 47 TABLE 12 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY END USE, 2019–2032 (USD MILLION) 49 TABLE 13 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR RETAIL PHARMACY,, BY COUNTRY, 2019–2032 (USD MILLION) 50 TABLE 14 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR INPATIENT PHARMACIES, BY COUNTRY, 2019–2032 (USD MILLION) 51 TABLE 15 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR OUTPATIENT PHARMACIES, BY COUNTRY, 2019–2032 (USD MILLION) 51 TABLE 16 NORTH AMERICA PHARMACY AUTOMATION MARKET, FOR PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES, BY COUNTRY, 2019–2032 (USD MILLION) 52 TABLE 17 NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 54 TABLE 18 US: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 55 TABLE 19 US: PHARMACY AUTOMATION MARKET FOR MEDICATION DISPENSING SYSTEMS, BY TYPE 2019–2032 (USD MILLION) 56 TABLE 20 US: PHARMACY AUTOMATION MARKET, BY END USE, 2019–2032 (USD MILLION) 56 TABLE 21 CANADA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 57 TABLE 22 CANADA: PHARMACY AUTOMATION MARKET FOR MEDICATION DISPENSING SYSTEMS, BY TYPE 2019–2032 (USD MILLION) 57 TABLE 23 CANADA: PHARMACY AUTOMATION MARKET, BY END USE, 2019–2032 (USD MILLION) 58 TABLE 24 MEXICO: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 58 TABLE 25 MEXICO: PHARMACY AUTOMATION MARKET FOR MEDICATION DISPENSING SYSTEMS, BY TYPE 2019–2032 (USD MILLION) 59 TABLE 26 MEXICO: PHARMACY AUTOMATION MARKET, BY END USE, 2019–2032 (USD MILLION) 59 TABLE 27 PUBLIC PLAYERS STOCK SUMMARY 63 TABLE 28 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 63 TABLE 29 PRODUCT LAUNCH 64 TABLE 30 COLLABORATION 64 TABLE 31 AGREEMENT 64 TABLE 32 ACQUISITION 65 TABLE 33 EXPANSION 65 TABLE 34 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW 67 TABLE 35 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 68 TABLE 36 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS 68 TABLE 37 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 69 TABLE 38 ACCU-CHART: PRODUCTS OFFERED 71 TABLE 39 CAPSA HEALTHCARE: PRODUCTS OFFERED 73 TABLE 40 CAPSA HEALTHCARE: KEY DEVELOPMENTS 73 TABLE 41 ARXIUM: PRODCUTS OFFERED 75 TABLE 42 BAXTER: PRODUCT OFFERED 77 TABLE 43 SCRIPTPRO LLC: PRODUCT OFFERED 80 TABLE 44 SWISSLOG HEALTHCARE: PRODUCT OFFERED 83 TABLE 45 OMNICELL, INC.: FINANCIAL OVERVIEW 85 TABLE 46 OMNICELL, INC.: PRODUCTS OFFERED 86 TABLE 47 OMNICELL, INC.: KEY DEVELOPMENTS 86 TABLE 48 MCKESSON CORPORATION: FINANCIAL OVERVIEW 89 TABLE 49 MCKESSON CORPORATION: PRODCUTS OFFERED 90 TABLE 50 PEARSON MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 93 LIST OF FIGURES FIGURE 1 NORTH AMERICA PHARMACY AUTOMATION MARKET: STRUCTURE 17 FIGURE 2 NORTH AMERICA PHARMACY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 34 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 36 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 37 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: NORTH AMERICA PHARMACY AUTOMATION MARKET 38 FIGURE 6 NORTH AMERICA PHARMACY AUTOMATION MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 42 FIGURE 7 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) 43 FIGURE 8 NORTH AMERICA PHARMACY AUTOMATION MARKET SHARE (%), BY PRODUCT, 2022 44 FIGURE 9 NORTH AMERICA PHARMACY AUTOMATION MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 48 FIGURE 10 NORTH AMERICA PHARMACY AUTOMATION MARKET, BY END USE, 2022 & 2032 (USD MILLION) 49 FIGURE 11 NORTH AMERICA PHARMACY AUTOMATION MARKET SHARE (%), BY END USE, 2022 50 FIGURE 12 NORTH AMERICA MARKET ANALYSIS: PHARMACY AUTOMATION MARKET, 2022-2032 (USD MILLION) 53 FIGURE 13 NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 54 FIGURE 14 NORTH AMERICA: PHARMACY AUTOMATION MARKET SHARE (%), BY COUNTRY, 2022 55 FIGURE 15 NORTH AMERICA PHARMACY AUTOMATION MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 61 FIGURE 16 COMPETITOR DASHBOARD: NORTH AMERICA PHARMACY AUTOMATION MARKET 62 FIGURE 17 BAXTER: FINANCIAL OVERVIEW SNAPSHOT 77 FIGURE 18 BAXTER: SWOT ANALYSIS 78 FIGURE 19 SCRIPTPRO LLC: SWOT ANALYSIS 81 FIGURE 20 OMNICELL, INC.: SWOT ANALYSIS 87 FIGURE 21 MCKESSON CORPORATION: SWOT ANALYSIS 91